What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

AI holds immense promise in accelerating drug discovery and development—but the journey from data to therapeutic impact is far from straightforward. Despite revolutionary breakthroughs, challenges ...

Registered Office: Newfrith House, 21 Hyde Street, Winchester, Hampshire, SO23 7DR, United Kingdom. Tel: +44 (0)208 191 8810 Email: [email protected] ...

Can AI turn data into drug candidates? Discover its role in drug discovery, from predictive biology to biomarkers data ...

What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

Currently, Illumina is comfortably the largest gene-sequencing company. But how did Illumina manage to monopolise the gene-sequencing market?

A new system that classifies genetic mutations that are likely treatable by a therapy that uses splice-switching antisense oligonucleotides (ASOs).

Figure 2. Computational strategies for single-cell multi-omics integration (A) Levels of input data – paired, partially paired and unpaired. (B) Techniques deployed in integration. Image Credit: Flynn ...

It is now possible to sequence an entire genome in just one day, due to the advent of next generation sequencing (NGS).

Analysis of proteins is not simple. Unlike DNA, there is incredible diversity in the concentration and variety of proteins created by a cell at any given moment. In our Proteomics Playbook we outline ...

Advances in protein sequencing enable deeper insights and facilitate applications such as biomarker discovery and personalised medicine.